CLOE — Clover Leaf Capital Income Statement
0.000.00%
- $8.64m
- $13.24m
Annual income statement for Clover Leaf Capital, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | 10-K | 10-K | 10-K |
Standards: | — | USG | USG | USG |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Other Operating Expenses | ||||
Total Operating Expenses | — | 0.852 | 1.29 | 1.59 |
Operating Profit | 0 | -0.852 | -1.29 | -1.59 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | — | -0.834 | 0.246 | -0.849 |
Provision for Income Taxes | ||||
Net Income After Taxes | — | -0.834 | 0.06 | -1.05 |
Net Income Before Extraordinary Items | ||||
Net Income | — | -0.834 | 0.06 | -1.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | 0 | -0.834 | 0.06 | -1.05 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | — | -0.046 | 0.004 | -0.183 |